Molecular classification of breast tumors: toward improved diagnostics and treatments.
about
Correcting for optimistic prediction in small data setsPolymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studiesWhat does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.Ethnic differences in breast cancer survival: status and determinants.Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.Mammographic density and molecular subtypes of breast cancer.Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancerLuminal B breast tumors are not HER2 positivePrevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.Immunohistochemical Assessment of Expression of Centromere Protein-A (CENPA) in Human Invasive Breast Cancer.Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors.The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines.Breast cancer subtypes: morphologic and biologic characterization.
P2860
Q30833438-E420C3A7-CC07-486A-9548-E76B495268D8Q33591401-EB258DA2-1FD6-4C15-B4FC-62CE2E712E6BQ33945022-2795480C-C950-4A3E-80B7-216E9C7F031EQ33990937-290F540A-E05C-42C5-AF4E-6827EEAA0DCDQ34303319-78061C36-0183-403D-BFC2-90A6BE339032Q34495412-BBC220DD-42B3-44A6-ACB0-BF3FE96B2FE4Q34977042-8097D3AD-C550-4F4B-B65C-3985714B1A6EQ35668954-26BD3968-51F8-4806-9E8E-E726C9A457A9Q35873283-E12A7089-BC75-4D3D-A6CB-9DC77C10E06DQ36075284-6E68EAC5-841B-48F7-831B-E7AB9A1D7859Q36410651-CEBAE5E7-6ABD-4225-AB96-C9EBA62C850EQ37038614-92BECE42-7725-47F3-BACA-6D0BCBC7F9E6Q37127021-B1D346E0-77F3-45DA-81AB-8A6F4B7BBCAAQ37148190-22010EA3-2A53-4A45-B097-310EA4667F52Q37221915-77C78D40-2788-4021-AAD4-37DCF2DEDE04Q37289219-4F708197-7131-4BAC-8030-E7287E655668Q39669204-B1298703-80E1-4E41-B73F-71DD330B9258Q49320962-D0F7D6BB-DBE4-47DC-9F3A-6831D6D2A513
P2860
Molecular classification of breast tumors: toward improved diagnostics and treatments.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Molecular classification of breast tumors: toward improved diagnostics and treatments.
@ast
Molecular classification of breast tumors: toward improved diagnostics and treatments.
@en
type
label
Molecular classification of breast tumors: toward improved diagnostics and treatments.
@ast
Molecular classification of breast tumors: toward improved diagnostics and treatments.
@en
prefLabel
Molecular classification of breast tumors: toward improved diagnostics and treatments.
@ast
Molecular classification of breast tumors: toward improved diagnostics and treatments.
@en
P356
P1476
Molecular classification of breast tumors: toward improved diagnostics and treatments.
@en
P304
P356
10.1385/1-59745-165-7:91
P407
P577
2007-01-01T00:00:00Z